Finance

Lists
ORCHPHARMA:NSE
Orchid Pharma Ltd
₹951.70
+2.47%
(+22.90) 1D
Aug 28, 12:30:30 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ORCHPHARMA...
Open
₹931.90
High
₹970.40
Low
₹924.95
Mkt. cap
56.99B
Avg. vol.
0.00
Volume
35.97K
P/E ratio
614.57
52-wk high
₹1,133.00
52-wk low
₹480.00
EPS
₹1.55
No. of employees
736
Open
₹931.90
High
₹970.40
Low
₹924.95
Mkt. cap
56.99B
Avg. vol.
0.00
Volume
35.97K
P/E ratio
614.57
52-wk high
₹1,133.00
52-wk low
₹480.00
EPS
₹1.55
No. of employees
736
Profile
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai. It was founded by Kailasam Raghavendra Rao on 1 July 1992. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
About Orchid Pharma Ltd
CEO-
Employees736
Founded1992
Headquarters-
SectorPharmaceutical industry
Websiteorchidpharma.com
Last report
Aug 21, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹0.54 / ₹3.60
-85.00%miss
Revenue / Est. (INR)
3.06B / 2.30B
+32.75%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.94B
2.07B
2.38B
3.06B
Cost of goods sold
1.33B
1.43B
1.51B
2.04B
Cost of revenue
1.33B
1.43B
1.51B
2.04B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
248.51M
241.28M
208.78M
280.38M
Operating expense
713.95M
715.86M
682.54M
968.16M
Total operating expenses
2.04B
2.15B
2.20B
3.01B
Operating income
-103.77M
-74.65M
179.97M
48.80M
Other non operating income
107.74M
56.09M
73.42M
-
EBT including unusual items
-57.24M
-126.14M
237.82M
32.97M
EBT excluding unusual items
-57.24M
-55.01M
232.43M
32.97M
Income tax expense
-
-
17.00K
723.00K
Effective tax rate
-
-
0.01%
2.19%
Other operating expenses
376.43M
384.29M
385.08M
578.29M
Net income
-57.24M
-126.14M
237.80M
32.24M
Net profit margin
-2.96%
-6.09%
10.01%
1.05%
Earnings per share
-1.13
-1.08
4.58
0.54
Interest and investment income
-
-
-
-
Interest expense
-37.32M
-31.78M
-30.91M
-22.30M
Net interest expenses
-37.32M
-31.78M
-30.91M
-22.30M
Depreciation and amortization charges
89.01M
90.29M
88.68M
109.49M
EBITDA
-15.99M
10.45M
268.60M
137.43M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps